Bioxytran Inc. Discusses The Use of BXT-25 as a Late Stage Treatment for the Coronavirus
Feb 12, 2020, 02:06 PM
The Stock Day Podcast welcomed Bioxytran, Inc. (BIXT)(“the Company”), a developmental stage biotechnology company. CEO of the Company, David Platt, joined Stock Day host Everett Jolly.